alexa

GET THE APP

�New� Drugs & International Regulatory Mechanisms | 6028
ISSN: 2155-9872

Journal of Analytical & Bioanalytical Techniques
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

�New� Drugs & International Regulatory Mechanisms

2nd International Conference on Analytical & Bioanalytical Techniques

S. V. Eswaran

ScientificTracks Abstracts: J Anal Bioanal Techniques

DOI: 10.4172/2155-9872.S1.02

Abstract
�The big players� continue to dominate the medicinal scene and such parameters are important when �incurable� diseases set in. Prevention rather than �treatment� of diseases needs to be emphasized. Interactions between hitherto undetected disease causing proteins (�small players�) are being targeted, whereby newer and better drugs are awaited in the forthcoming era of personalized medicine. Anti-fungals based on �Click� reaction have been developed by the author. Fift y fi ve years since the discovery of the last vitamin, Pyrroloquinoline quinone (PQQ) is now recognized as the 14 th vitamin. To be useful as a vitamin, it has to available at low cost. Th e author�s work on �true nitrene� based homo and hetero bifunctional crosslinkers for proteomics and lipidomics could be useful for chemical crosslinking-mass spectrometry based rapid and reliable high throughput screening (HTS) of large number of samples routinely. Soluble Fullerenes and SWCNT developed in my laboratory have been shown to be compatible with blood for nano-drug delivery. Norms for drug approvals becoming very stringent worldwide, discovery of new drug entities has now become very diffi cult. As ways are found for overcoming these, many issues arise, which need to be adjudged in an equitable and fair manner. Serving as a �Local Commisioner� in cases of drug fi rms at an international level has been a learning experience for the author. Th e use of modern instrumentation for regulatory purposes is to be strongly advocated. Open Source Drug Discovery (OSDD), a laudable initiative has also provided the author much needed stimulus.
Biography

Dr S. V. Eswaran, Head, Chemistry Department and Dean, (Academics), St. Stephen?s College, University of Delhi, Delhi and has taught there for 42 years. Served as Principal, Deshbandhu College, Delhi for two years and as a member for many national committees. Ph. D., Delhi, 1973; Post-Doc. Max Planck, Munich, 1976-77; Heidelberg, Karlsruhe, 1984; Goettingen, 1997, Germany; TU, Delft, Netherlands,1990; Ohio State University, 1997; Brown University, 2006, USA. Best teacher award, 2007; distinguished teacher award, 2009; DADD fellowship, 1976-77. Published 60 papers, granted many patents and supervised 4 Ph. D. and 21 M. sc/ M. Tech.. thesis.

Top